节点文献

维思通治疗精神分裂症疗效与PANSS应用的初步研究

A preliminary study of efficacy of risperidone on treating schizophrenia and clinical application of PANSS

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 赵靖平陈晓刚陈远光

【Author】 Zhao Jingping,Chen Xiaogang,Chen Yuangguang.Mental Health Institute,The Second Affiliated Hospital of Hunan Medical University(410011)

【机构】 湖南医科大学精神卫生研究所

【摘要】 目的初步研究维思通治疗精神分裂症的疗效和不良反应,以及PANSS的临床适用性。方法20例病人用维思通治疗八周,用PANSS、CGI和GAS评定疗效,ESRS和实验室检查评价不良反应。结果维思通对阳性和阴性分裂症状有效,起效较快。不良反应有轻度锥外反应和激越。PANSS的平行效度和内部一致性尚可。结论维思通对精神分裂症有效且安全性高。PANSS适合做为精神分裂症的评定工具

【Abstract】 Objective To engage a preliminary study on efficacy and adverse reaction for treating schizophrenia with risperidone and clinical acceptability of PANSS. Methods 20 cases of schizophrenic patients were treated by risperidone for eight weeks,using PANSS,CGI and GAS for evaluating therapeutic effects,ESRS and related laboratory tests for assessing side effects. Results It showed that both positive and negative symptoms were markedly improved by risperidone and less adverse reaction was found.The comparative validity and inner reliability of PANSS were acceptable. Conclusion Risperidone can offer safer and more efficacy for treatment of schizophrenia as a newer atypical neuroleptics.

【关键词】 维思通PANSS精神分裂症
【Key words】 Risperidone PANSS Schizophrenia
  • 【文献出处】 四川精神卫生 ,SICHUAN MENTAL HEALTH , 编辑部邮箱 ,1998年01期
  • 【分类号】R971.41
  • 【被引频次】14
  • 【下载频次】110
节点文献中: 

本文链接的文献网络图示:

本文的引文网络